Gene Logic Shares Toxicogenomics Data with FDA’s IPRG in Wake of 44 Percent Drop in Revenues, Layoffs | GenomeWeb
In the wake of major layoffs and disappointing second-quarter earnings, Gene Logic said last week that it will share toxicogenomics data with the US Food and Drug Administration for use in evaluating voluntary genomic data submissions.
The company’s total revenues for the second quarter were down 44 percent due to the underperformance of its genomics segment — the same segment for which Gene Logic officials previously expressed optimism for growth in 2006.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.